持田製薬株式会社 · Pharmaceutical · FY ends Mar
| # | Shareholder | Shares | Stake | Value | Dividends |
|---|---|---|---|---|---|
| 1 | 公益財団法人持田記念医学薬学振興財団 | 5,688,000 | 16.05% | ¥19.7B | ¥455M |
| 2 | 日本マスタートラスト信託銀行株式会社 | 2,981,000 | 8.41% | ¥10.3B | ¥238M |
| 3 | 公益財団法人高松宮妃癌研究基金 | 1,683,000 | 4.75% | ¥5.8B | ¥135M |
| 4 | 株式会社三菱UFJ銀行 | 1,586,000 | 4.48% | ¥5.5B | ¥127M |
| 5 | みずほ信託銀行株式会社 退職給付信託みずほ銀行口 再信託受託者株式会社日本カストディ銀行 | 1,434,000 | 4.05% | ¥5.0B | ¥115M |
| 6 | Nissui Co., Ltd. | 1,200,000 | 3.39% | ¥4.1B | ¥96.0M |
| 7 | Naoyuki Mochida | 1,023,000 | 2.89% | ¥3.5B | ¥81.8M |
| 8 | Takeshi Mochida | 949,000 | 2.68% | ¥3.3B | ¥75.9M |
| 9 | Kazue Mochida | 787,000 | 2.22% | ¥2.7B | ¥63.0M |
| 10 | Taisho Pharmaceutical Holdings Co., Ltd. | 785,000 | 2.21% | ¥2.7B | ¥62.8M |
| Name | Title | Shares | Value | Pay |
|---|---|---|---|---|
| Naoyuki Mochida | Representative Director | 1,023,200 | ¥3.5B | — |
| 榊 潤一 | Representative Director | 13,100 | ¥45.3M | — |
| 三石 基 | Representative Director | 2,900 | ¥10.0M | — |
| 川上 裕 | Director | 8,300 | ¥28.7M | — |
| 根津 淳一 | Director | 1,400 | ¥4.8M | — |
| 宮嶋 謙二 | Director | 2,600 | ¥9.0M | — |
| 坂田 中 | Director | 18,000 | ¥62.2M | — |
| 園田 智昭 | Director | 1,300 | ¥4.5M | — |
| 吉川 惠章 | Director | 1,400 | ¥4.8M | — |
| 小林 麻実 | Director | 1,100 | ¥3.8M | — |
| 田中 早苗 | Director | 1,200 | ¥4.1M | — |
| 橋本 好晴 | Full-time Audit & Supervisory Board Member | 5,700 | ¥19.7M | — |
| 竹田 雅好 | Full-time Audit & Supervisory Board Member | 2,300 | ¥7.9M | — |
| 和貝 享介 | Audit & Supervisory Board Member | 2,900 | ¥10.0M | — |
| 鈴木 明子 | Audit & Supervisory Board Member | 2,900 | ¥10.0M | — |
| 宮田 芳文 | Audit & Supervisory Board Member | 1,200 | ¥4.1M | — |
Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.
| Fiscal year | Price | EPS | P/E | Dividend | Shares issued |
|---|---|---|---|---|---|
| FY ending Mar 2026 | ¥3,456 | ¥222.96 | 15.5x | ¥80.0 | 36,390,000 |
| FY ending Mar 2025 | ¥3,175 | ¥160.36 | 19.8x | ¥80.0 | 36,390,000 |